A 52-year-old man with established RA on methotrexate 20 mg weekly has persistent moderate disease activity (DAS28 4.8) despite 12 weeks of therapy. He has no contraindications to biologics. Which is the preferred next step in pharmacotherapy?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.